Researchers at the Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, have introduced Void-X, a novel generative artificial intelligence model that enables atomic-level design of protein interfaces. Published recently in the Proceedings of the National Academy of Sciences, the model addresses a critical bottleneck in computational biology by shifting from traditional top-down structural approaches to a bottom-up atomic filling paradigm. While generative AI has significantly accelerated de novo protein design, most existing frameworks rely on top-down strategies that construct overall protein architectures before refining functional sites. Void-X diverges from this convention by directly generating precise atomic distributions tailored to specific structural regions. Designed as an atomic filling model, Void-X captures microscopic interaction patterns and fills spatial voids at protein-protein or protein-drug interfaces, establishing a physically interpretable foundation for biomolecular engineering. This capability aligns with advancing delivery technologies, such as adeno-associated viruses and mRNA lipid nanoparticles, which increasingly require tissue-specific, precisely engineered therapeutic proteins. To train the model, the research team curated a dataset exceeding eight million spherical atomic clusters extracted from established protein databases. During training, approximately thirty percent of peripheral, spatially contiguous atoms within each cluster were masked to predict missing atomic configurations, while the remaining atoms provided contextual structural information. The architecture comprises 170 million parameters and demonstrates robust predictive performance, achieving an accuracy of 78.3 percent in intra-chain atomic cluster prediction and 68.2 percent in inter-chain predictions. By seamlessly integrating atomic-scale precision with generative modeling, Void-X enables direct synthesis of atomic-level interaction networks without prior global shape constraints. This bottom-up methodology expands the rational design toolkit for protein therapeutics, with immediate applications in targeted drug discovery, vaccine development, and precision medicine. The model lays the groundwork for engineering complex biomolecular interfaces with unprecedented accuracy, potentially reducing the timeline for novel therapeutic pipeline development. The research received financial support from the National Natural Science Foundation of China and the Chinese Academy of Sciences. Full methodological details and performance benchmarks are available in the recent PNAS publication.